CompletedNot Applicable

Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD

Taiwan51 participantsStarted 2016-05-17

Plain-language summary

This study explores the acute exercise effect on neurocognitive function and also its potential moderators in an exercise setting and Apolipoprotein E (APOE) genetic risk.

Who can participate

Age range50 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults aged between 50 and 70 years old
✓. Normal or corrected-to-normal vision based on the minimal 20/20 standard
✓. Cognitively normal as mini-mental state examination scores (MMSE) \> 26

Exclusion criteria

✕. Neurological or psychiatric disorders
✕. Cardiovascular disease
✕. Risk of cardiovascular fitness assessment based on the Physical Activity Readiness Questionnaire (PAR-Q)
✕. Red-green color blindness.

What they're measuring

Stroop task: Response time

Timeframe: Participants were required to complete the Stroop task approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

Stroop task: Accuracy

Timeframe: Participants were required to complete the Stroop task approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

Event-related potential: P3 amplitude

Timeframe: Participants were required to complete the Stroop task while EEG activity was continuously recorded approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

Trial details

NCT IDNCT05591313

SponsorNational Taiwan Normal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-26

View on ClinicalTrials.gov More Alzheimer Disease 2 Due to Apoe4 Isoform trials